Gamma-aminobutyric acid type A receptor alpha-2 subunit-containing complex (GABA_A receptor α2βxγ2)

The GABA_A receptor α2βxγ2 is a specific subtype of the ionotropic gamma-aminobutyric acid (GABA) receptor, which serves as the primary inhibitory neurotransmitter receptor in the mammalian central nervous system. It is a pentameric ligand-gated ion channel typically composed of two alpha-2 subunits, two beta subunits, and one gamma-2 subunit. This receptor subtype is predominantly localized in the hippocampus, amygdala, and striatum, regions critical for emotional regulation and cognitive processing. Biologically, it mediates the anxiolytic, analgesic, and anticonvulsant effects of GABAergic signaling, distinguishing it from the alpha-1 subtype which primarily mediates sedation. In disease contexts, the alpha-2 subunit is strongly linked to the pathogenesis of anxiety disorders, chronic pain, and epilepsy. Furthermore, genetic polymorphisms in the GABRA2 gene are significantly associated with a predisposition to alcohol use disorder and impulsive behavior. Pharmacologically, the receptor is a major target for benzodiazepines and is the focus of drug development for subtype-selective positive allosteric modulators that aim to provide therapeutic relief without sedative side effects.

Other names

GABRA2GABA(A) receptor subunit alpha-2Alpha-2 containing GABA-A receptorGABAAR subunit alpha-2

Positive allosteric modulation of the chloride ion channel via the benzodiazepine binding site located at the alpha/gamma subunit interface [2, 9]